Mallinckrodt Puts Off Planned Generics Spinoff Amid Opioid Cases

(Bloomberg) -- Mallinckrodt Plc said it would suspend the spinoff of its specialty-generics business as it grapples with a wave of lawsuits related to opioid painkillers and a bruising marketplace ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.